Literature DB >> 32212994

PCR Detection of Oxacillinases in Bacteria.

Patrik Mlynarcik1, Andrea Chalachanova2, Iva Vagnerovă1, Ondrej Holy3, Simona Zatloukalova3, Milan Kolar1,4.   

Abstract

Oxacillinases (OXA) have been mostly described in Enterobacteriaceae, Acinetobacter, and Pseudomonas species. Recent years have witnessed an increased prevalence of intrinsic and/or acquired β-lactamase-producing Acinetobacter in food-producing animals. This study was conducted to assess the prevalence of OXA among selected bacterial species and to characterize these enzymes by in silico analysis. Screening of OXA was performed by PCR amplification using specific pairs of oligonucleotides. Overall, 40 pairs of primers were designed, of which 6 were experimentally tested in vitro. Among 49 bacterial isolates examined, the presence of blaOXA-1-like genes was confirmed in 20 cases (41%; 19 times in Klebsiella pneumoniae and once in Enterobacter cloacae). No OXA were found in animal isolates. The study results confirmed the specificity of the designed oligonucleotide pairs. Furthermore, the designed primers were found to possess the ability to specifically detect 90.2% of all OXA. These facts suggest that the in silico and in vitro tested primers could be used for single or multiplex PCR to screen for the presence of OXA in various bacteria, as well as to monitor their spread. At the same time, the presence of conserved characteristic amino acids and motifs was confirmed by in silico analysis of sequences of representative members of OXA.

Entities:  

Keywords:  PCR; antibiotic resistance; oxacillinases; primers

Mesh:

Substances:

Year:  2020        PMID: 32212994     DOI: 10.1089/mdr.2019.0330

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  1 in total

1.  Investigating the OXA Variants of ESKAPE Pathogens.

Authors:  Deeksha Pandey; Neelja Singhal; Manish Kumar
Journal:  Antibiotics (Basel)       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.